达安基因 (002030)

Daan Gene Co., Ltd.

ASZ

Tags

Internet FinanceArtificial Intelligence (AI)Venture Capital ConceptPharmaceutical ManufacturingInvestments in Newly Listed CompaniesGene ConceptHelicobacter PyloriBiological VaccinesHepatitis ConceptEquity TransferMargin Trading and Securities LendingChina Securities Finance and Central Huijin HoldingsAssisted ReproductionFood SafetyUniversity Background

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 140344.60
  • Circulating A-Shares(W): 140344.60
  • Earnings Per Share(RMB): -0.1000
  • Net Assets Per Share(RMB): 5.5155
  • Operating Revenue(W RMB): 50350.69
  • Total Profit(W RMB): -16957.33
  • Net Profit Attributable to Parent(W RMB): -14150.46
  • Net Profit Growth Rate(%): 71.85
  • Weighted Return on Equity(%): -1.8100
  • Operating Cash Flow Per Share(RMB): 0.0580
  • Undistributed Profit Per Share(RMB): 3.1849
  • Capital Reserve Per Share(RMB): 0.4301

2. Main Business

The main business covers:

  • Research, production, and sales of clinical testing reagents, instruments, and supporting consumables.

3. Company Basic Information

  • Company Name: Daan Gene Co., Ltd.
  • Listing Date: 2004-08-09
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 19 Xiangshan Road, Science City, High-tech Industrial Development Zone, Guangzhou, Guangdong Province, China
  • Website: www.daangene.com
  • Company Profile：The company was established by the overall change and initiation of Sun Yat-sen Medical University Daan Gene Co., Ltd. The initiators included Sun Yat-sen Medical University (later merged with the original Sun Yat-sen University and collectively referred to as Sun Yat-sen University), Guangzhou Bioengineering Center, Wang Youming, Hongta Investment, Dongsheng Investment, Liu Qiang, Guosen Securities, Tongchuang Weiye, He Yunshao, Cheng Gang, Zhou Xinyu, and Wu Junsheng. The registered capital at the time of establishment was 34.70 million yuan. After two distributions of bonus shares from distributable profits to shareholders in 2001 and 2002, the current registered capital is 61.60 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangzhou Guangyong Technology Development Co., Ltd. General Legal Person 23339.20 16.63
2 Guangzhou Biomedical and Health Industry Investment Co., Ltd. General Legal Person 14034.46 10.00
3 Guangzhou Financial Holding Group Co., Ltd. General Legal Person 7017.23 5.00
4 Central Huijin Asset Management Co., Ltd. Special Legal Person 1281.79 0.91
5 Hong Kong Securities Clearing Company Ltd. Northbound Funds 1112.01 0.79
6 Yongwin CSI All Share Medical Devices ETF Fund 605.85 0.43

5. Concept Sectors

  • Venture Capital Concept
  • Biological Vaccine
  • Food Safety
  • Internet Finance
  • Gene Concept
  • Artificial Intelligence
  • Helicobacter Pylori
  • Assisted Reproduction
  • Hepatitis Concept
  • Margin Trading & Securities Lending
  • University Background
  • Participation in New Share Issuance
  • Consecutive Losses
  • National Team (Central Huijin & China Securities Finance)
  • Equity Transfer

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information